Diabetes Overview – Checking on promising tools from Dexcom, Bigfoot Biomedical and Senseonics
This week we’ll focus on a few of the exciting companies in the diabetes space.
Associate Editor Sean Whooley first tracks down Dexcom CEO Kevin Sayer, who discusses the company’s next-generation G7 continuous glucose monitor, which is awaiting FDA approval.
Then, Sean speaks with Bigfoot Biomedical CEO Jeffrey Brewer to learn more about what he calls “a transformational attempt” to simplify CGMs with an all-in-one platform with a smart insulin pen cap.
Finally, Sean interviews Senseonics CMO Dr. Francine Kaufman about
the company’s Eversense 180-day CGM, which just received FDA approval.
Chris Newmarker brings his Newsmakers of the week including Amazon, Thermo Fisher, HeartFlow, Abbott, Cooper Company and Cook Medical.
This episode was sponsored by Accumold.
Subscribe to this podcast on major podcast channels.
Associate Editor Sean Whooley first tracks down Dexcom CEO Kevin Sayer, who discusses the company’s next-generation G7 continuous glucose monitor, which is awaiting FDA approval.
Then, Sean speaks with Bigfoot Biomedical CEO Jeffrey Brewer to learn more about what he calls “a transformational attempt” to simplify CGMs with an all-in-one platform with a smart insulin pen cap.
Finally, Sean interviews Senseonics CMO Dr. Francine Kaufman about
the company’s Eversense 180-day CGM, which just received FDA approval.
Chris Newmarker brings his Newsmakers of the week including Amazon, Thermo Fisher, HeartFlow, Abbott, Cooper Company and Cook Medical.
This episode was sponsored by Accumold.
Subscribe to this podcast on major podcast channels.
Activity